genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2024
X-linked genetic diseases
Drug Discovery
Signal Peptide Harnesses Exosomes for Precise Drug Delivery
Drug Discovery
Novartis Buys Kate Therapeutics, Expanding in Neuro Gene Therapy
Genome Editing
Gene Therapy for Muscular Dystrophy Could Use StitchR to Assemble XL Gene from S Segments
Genome Editing
PAMless Base Editors Correct X-CGD Mutation Efficiently and Precisely
Drug Discovery
Digital Twins of Biological Systems Inform Drug Development
Cancer
New Computational Model Matches Drugs to Protein Synthesis Disruptors in Hereditary Diseases, Cancer
Drug Discovery
StockWatch: Cognition Stays the Course as Shares Plunge on Alzheimer’s Data
GEN Edge
StockWatch: Phase III Data for Pfizer-Partnered Hemophilia A Gene Therapy Lifts Sangamo Shares
GEN Edge
StockWatch: “Final Resolution” Set for Illumina’s Grail Saga
Artificial Intelligence
ASGCT 2024: Interview with Frédéric Revah, CEO of Généthon
1
2
3
...
20
Page 1 of 20
Scroll Up
Scroll Up
